EMAIL THIS PAGE TO A FRIEND

Molecular Cancer Therapeutics

ANG4043, a novel brain-penetrant peptide-mAb conjugate, is efficacious against HER2-positive intracranial tumors in mice.


PMID 25492620

Abstract

We're sorry this abstract is currently not available.